Search research articles
Contact Us
Filters
Showing results (301-310 of 324) with videos related to
Page
of 33
Sort By:
Chemical Biology & Drug Design
|
September 18, 2012
Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L
Aravind Basavapathruni, Lei Jin, Scott R Daigle, et al.
Cancer Research
|
November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
J D Moyer, E G Barbacci, K K Iwata, et al.
Plos One
|
December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
Sarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
The Journal of Infectious Diseases
|
September 28, 2001
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study
F Y Lin, J B Philips, P H Azimi, et al.
Wetlands (Wilmington, N.C.)
|
June 26, 2023
An Improved Framework for Estimating Organic Carbon Content of Mangrove Soils Using loss-on-ignition and Coastal Environmental Setting
Joshua L Breithaupt, Havalend E Steinmuller, Andre S Rovai, et al.
Blood
|
June 27, 2013
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R Daigle, Edward J Olhava, Carly A Therkelsen, et al.
Nature Communications
|
June 8, 2021
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
Parisa Hosseinzadeh, Paris R Watson, Timothy W Craven, et al.
ACS Medicinal Chemistry Letters
|
June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound
Lorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
John E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 324) with videos related to
Sort By:
Page
of 33
Chemical Biology & Drug Design
|
September 18, 2012
Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1L
Aravind Basavapathruni, Lei Jin, Scott R Daigle, et al.
Cancer Research
|
November 14, 1997
Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
J D Moyer, E G Barbacci, K K Iwata, et al.
Plos One
|
December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin Lymphomas
Sarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
The Journal of Infectious Diseases
|
September 28, 2001
Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study
F Y Lin, J B Philips, P H Azimi, et al.
Wetlands (Wilmington, N.C.)
|
June 26, 2023
An Improved Framework for Estimating Organic Carbon Content of Mangrove Soils Using loss-on-ignition and Coastal Environmental Setting
Joshua L Breithaupt, Havalend E Steinmuller, Andre S Rovai, et al.
Blood
|
June 27, 2013
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R Daigle, Edward J Olhava, Carly A Therkelsen, et al.
Nature Communications
|
June 8, 2021
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
Parisa Hosseinzadeh, Paris R Watson, Timothy W Craven, et al.
ACS Medicinal Chemistry Letters
|
June 24, 2015
Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound
Lorna H Mitchell, Allison E Drew, Scott A Ribich, et al.
ACS Medicinal Chemistry Letters
|
March 18, 2016
Structure and Property Guided Design in the Identification of PRMT5 Tool Compound EPZ015666
Kenneth W Duncan, Nathalie Rioux, P Ann Boriack-Sjodin, et al.
ACS Medicinal Chemistry Letters
|
May 26, 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
John E Campbell, Kevin W Kuntz, Sarah K Knutson, et al.
Page
of 33